BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 15154850)

  • 1. The CBP/p300 TAZ1 domain in its native state is not a binding partner of MDM2.
    Matt T; Martinez-Yamout MA; Dyson HJ; Wright PE
    Biochem J; 2004 Aug; 381(Pt 3):685-91. PubMed ID: 15154850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of the TAZ1 domain of the CREB-binding protein with the activation domain of CITED2: regulation by competition between intrinsically unstructured ligands for non-identical binding sites.
    De Guzman RN; Martinez-Yamout MA; Dyson HJ; Wright PE
    J Biol Chem; 2004 Jan; 279(4):3042-9. PubMed ID: 14594809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CBP/p300 TAZ1 domain forms a structured scaffold for ligand binding.
    De Guzman RN; Wojciak JM; Martinez-Yamout MA; Dyson HJ; Wright PE
    Biochemistry; 2005 Jan; 44(2):490-7. PubMed ID: 15641773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human homologue of yeast Rad23 protein A interacts with p300/cyclic AMP-responsive element binding (CREB)-binding protein to down-regulate transcriptional activity of p53.
    Zhu Q; Wani G; Wani MA; Wani AA
    Cancer Res; 2001 Jan; 61(1):64-70. PubMed ID: 11196199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2.
    Ferreon JC; Lee CW; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
    Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6591-6. PubMed ID: 19357310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solution structure of the TAZ2 (CH3) domain of the transcriptional adaptor protein CBP.
    De Guzman RN; Liu HY; Martinez-Yamout M; Dyson HJ; Wright PE
    J Mol Biol; 2000 Oct; 303(2):243-53. PubMed ID: 11023789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for Hif-1 alpha /CBP recognition in the cellular hypoxic response.
    Dames SA; Martinez-Yamout M; De Guzman RN; Dyson HJ; Wright PE
    Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5271-6. PubMed ID: 11959977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDMX inhibits the p300/CBP-mediated acetylation of p53.
    Sabbatini P; McCormick F
    DNA Cell Biol; 2002 Jul; 21(7):519-25. PubMed ID: 12162806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of transcription factor C/ATF by the cAMP signal activation in hippocampal neurons, and molecular interaction of C/ATF with signal integrator CBP/p300.
    Yukawa K; Tanaka T; Tsuji S; Akira S
    Brain Res Mol Brain Res; 1999 May; 69(1):124-34. PubMed ID: 10350644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyubiquitination of p53 by a ubiquitin ligase activity of p300.
    Grossman SR; Deato ME; Brignone C; Chan HM; Kung AL; Tagami H; Nakatani Y; Livingston DM
    Science; 2003 Apr; 300(5617):342-4. PubMed ID: 12690203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal activators that bind to the KIX domain of p300/CBP identified by phage display screening.
    Frangioni JV; LaRiccia LM; Cantley LC; Montminy MR
    Nat Biotechnol; 2000 Oct; 18(10):1080-5. PubMed ID: 11017047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis of the p300 acetyltransferase domain: the PHD finger of p300 but not of CBP is dispensable for enzymatic activity.
    Bordoli L; Hüsser S; Lüthi U; Netsch M; Osmani H; Eckner R
    Nucleic Acids Res; 2001 Nov; 29(21):4462-71. PubMed ID: 11691934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine double minute (MDM2) blocks p53-coactivator interaction, a new mechanism for inhibition of p53-dependent gene expression.
    Wadgaonkar R; Collins T
    J Biol Chem; 1999 May; 274(20):13760-7. PubMed ID: 10318779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p300/MDM2 complexes participate in MDM2-mediated p53 degradation.
    Grossman SR; Perez M; Kung AL; Joseph M; Mansur C; Xiao ZX; Kumar S; Howley PM; Livingston DM
    Mol Cell; 1998 Oct; 2(4):405-15. PubMed ID: 9809062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of p53 degradation by Mdm2 acetylation.
    Wang X; Taplick J; Geva N; Oren M
    FEBS Lett; 2004 Mar; 561(1-3):195-201. PubMed ID: 15013777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of PIMT with transcriptional coactivators CBP, p300, and PBP differential role in transcriptional regulation.
    Misra P; Qi C; Yu S; Shah SH; Cao WQ; Rao MS; Thimmapaya B; Zhu Y; Reddy JK
    J Biol Chem; 2002 May; 277(22):20011-9. PubMed ID: 11912212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining the molecular basis of Arf and Hdm2 interactions.
    Bothner B; Lewis WS; DiGiammarino EL; Weber JD; Bothner SJ; Kriwacki RW
    J Mol Biol; 2001 Nov; 314(2):263-77. PubMed ID: 11718560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p300 relieves p53-evoked transcriptional repression of hypoxia-inducible factor-1 (HIF-1).
    Schmid T; Zhou J; Köhl R; Brüne B
    Biochem J; 2004 May; 380(Pt 1):289-95. PubMed ID: 14992692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CBP as a transcriptional coactivator of c-Myb.
    Dai P; Akimaru H; Tanaka Y; Hou DX; Yasukawa T; Kanei-Ishii C; Takahashi T; Ishii S
    Genes Dev; 1996 Mar; 10(5):528-40. PubMed ID: 8598284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A transcription-factor-binding surface of coactivator p300 is required for haematopoiesis.
    Kasper LH; Boussouar F; Ney PA; Jackson CW; Rehg J; van Deursen JM; Brindle PK
    Nature; 2002 Oct; 419(6908):738-43. PubMed ID: 12384703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.